PTC Therapeutics (PTCT) total liabilities

Total liabilities · fiscal 2025
$3.10B

PTC Therapeutics (PTCT) had total liabilities of $3.10B at the end of fiscal 2025 (December 31, 2025). That is 10.7% higher than the $2.80B of fiscal 2024. Figures as of 19 Nov 2026, 02:44 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total liabilities, fiscal 2025
$3.10B
Change on fiscal 2024
+10.7%
Growth, 5 years
+12.5% a year
Growth, 10 years
+36.4% a year
Highest on record
$3.10Bfiscal 2025
Lowest on record
$15.36Mfiscal 2013
Fiscal years on record
142012–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

PTC Therapeutics total liabilities, in more detail

Over the five fiscal years to 2025 total liabilities grew at a compound 12.5% a year; over ten years the rate was 36.4% a year. Across the 14 fiscal years on record (2012–2025), the highest was $3.10B in fiscal 2025 and the lowest $15.36M in fiscal 2013.

History · 14 fiscal years

Total liabilities by fiscal year

PTC Therapeutics total liabilities, year by year

PTC Therapeutics (PTCT) total liabilities by fiscal year
Fiscal yearTotal liabilitiesChangeYear ended
2025$3.10B 10.7% up
2024$2.80B 3.3% up
2023$2.71B 32.2% up
2022$2.05B 6.0% up
2021$1.94B 12.2% up
2020$1.73B 67.7% up
2019$1.03B 34.0% up
2018$768.50M 226.7% up
2017$235.22M 57.1% up
2016$149.76M 7.5% up
2015$139.28M 300.8% up
2014$34.75M 126.2% up
2013$15.36M 51.8% down
2012$31.89M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total liabilities is everything the company owes at the fiscal year-end — borrowings, payables, deferred revenue, lease and pension obligations and the rest.

How to read it

It is broader than debt: read it against total assets, and remember that for a bank or an insurer customer deposits and policy reserves are liabilities too.

Total liabilities at health care companies of similar size

Total liabilities of PTC Therapeutics and comparable companies
CompanyTotal liabilitiesFiscal year
Hims & Hers Health HIMS$1.61B2025
PTC Therapeutics PTCT$3.10B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on PTCT

PTC Therapeutics, figure by figure

PTC Therapeutics (PTCT) overview: price, valuation and scorecardAll health care companies by market value

PTC Therapeutics total liabilities: questions and answers

How large are PTC Therapeutics's total liabilities?

PTC Therapeutics (PTCT) had total liabilities of $3.10B at the end of fiscal 2025 (December 31, 2025). That is 10.7% higher than the $2.80B of fiscal 2024.

What is the growth rate of PTC Therapeutics's total liabilities?

Over the five fiscal years to 2025 total liabilities grew at a compound 12.5% a year; over ten years the rate was 36.4% a year.

What are the highest and lowest total liabilities figures on record for PTC Therapeutics?

Across the 14 fiscal years on record (2012–2025), the highest was $3.10B in fiscal 2025 and the lowest $15.36M in fiscal 2013.

How is PTC Therapeutics's total liabilities calculated?

Total liabilities is everything the company owes at the fiscal year-end — borrowings, payables, deferred revenue, lease and pension obligations and the rest. For PTC Therapeutics it is on record here for 14 fiscal years, 2012 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “PTC Therapeutics (PTCT) total liabilities”, data as of 19 November 2026. https://funkfolio.com/stock/PTCT/total-liabilities

Underlying data: the company's filings with the SEC and Yahoo Finance.